普瑞巴林市场：按剂型、效力、用途、最终用户、通路 - 全球预测 2023-2030

普瑞巴林的全球市场预计将大幅成长，预计2023年将达到11.2638亿美元，年复合成长率为7.67%，预计2030年将达到18.989亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球普瑞巴林市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.普瑞巴林全球市场规模及预测为何？

2.在预测期内，COVID-19对全球普瑞巴林市场的阻碍因素与影响为何？

3. 在预测期内，全球普瑞巴林市场需要投资哪些产品/细分市场/应用/领域？

4.普瑞巴林在全球市场的竞争策略为何？

5. 普瑞巴林全球市场的技术趋势和法律规范是什么？

6.全球普瑞巴林市场主要厂商的市占率为何？

7. 哪些型态和策略措施被认为适合普瑞巴林进入全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 癫痫和焦虑症病例呈上升趋势
    • 政府采取有利措施提高对不安全问题的认识
    • 患有神经性疼痛的老年人口不断增加
  • 抑制因素
    • 替代品的存在与缺乏意识
  • 机会
    • 仿製药批准增加
    • 普瑞巴林的进展与产品改进
  • 任务
    • 不良健康影响和产品召回
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章普瑞巴林市场按剂型

• 缓释
• 口服胶囊
• 口服液
• 口服锭剂

第7章依药物类别分類的普瑞巴林市场

• 抗惊厥药
• 纤维肌痛治疗药物

第8章普瑞巴林市场：依用途

• 焦虑症
• 癫痫
• 神经性疼痛

第9章普瑞巴林市场：依最终用户分类

• 居家护理
• 医院
• 调查机构
• 专科诊所

第10章普瑞巴林市场：依通路分类

• 医院药房
• 网路药房
• 零售药房

第11章美洲普瑞巴林市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第12章亚太普瑞巴林市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第13章欧洲、中东和非洲普瑞巴林市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第14章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第15章上市公司名单

第16章附录

• 讨论指南
• 关于许可证和定价

The Global Pregabalin Market is forecasted to grow significantly, with a projected USD 1,126.38 million in 2023 at a CAGR of 7.67% and expected to reach a staggering USD 1,898.90 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pregabalin Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pregabalin Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Dosage Forms, market is studied across Extended Release, Oral Capsule, Oral Solution, and Oral Tablet. The Oral Solution is projected to witness significant market share during forecast period.

Based on Drug Class, market is studied across Anticonvulsants and Fibromyalgia Agents. The Anticonvulsants is projected to witness significant market share during forecast period.

Based on Application, market is studied across Anxiety Disorder, Epilepsy, and Neuropathic Pain. The Epilepsy is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Homecare, Hospitals, Research institute, and Specialty Clinics. The Hospitals is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Retail Pharmacy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pregabalin Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pregabalin Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pregabalin Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pregabalin Market?

4. What is the competitive strategic window for opportunities in the Global Pregabalin Market?

5. What are the technology trends and regulatory frameworks in the Global Pregabalin Market?

6. What is the market share of the leading vendors in the Global Pregabalin Market?

7. What modes and strategic moves are considered suitable for entering the Global Pregabalin Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Pregabalin Market, by Dosage Forms, 2022 vs 2030
• 4.3. Pregabalin Market, by Drug Class, 2022 vs 2030
• 4.4. Pregabalin Market, by Application, 2022 vs 2030
• 4.5. Pregabalin Market, by End-Users, 2022 vs 2030
• 4.6. Pregabalin Market, by Distribution Channel, 2022 vs 2030
• 4.7. Pregabalin Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of epilepsy and anxiety disorders
    • 5.1.1.2. Favorable government initiatives for raising awareness for anxiety issues
    • 5.1.1.3. Rising geriartic population with neuropathic pain
  • 5.1.2. Restraints
    • 5.1.2.1. Presence of substitutes and lack of awareness
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising approvals of generic versions of the medicine
    • 5.1.3.2. Advancements and product enhancements for pregabalin
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects on health and product recalls
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Pregabalin Market, by Dosage Forms

• 6.1. Introduction
• 6.2. Extended Release
• 6.3. Oral Capsule
• 6.4. Oral Solution
• 6.5. Oral Tablet

7. Pregabalin Market, by Drug Class

• 7.1. Introduction
• 7.2. Anticonvulsants
• 7.3. Fibromyalgia Agents

8. Pregabalin Market, by Application

• 8.1. Introduction
• 8.2. Anxiety Disorder
• 8.3. Epilepsy
• 8.4. Neuropathic Pain

9. Pregabalin Market, by End-Users

• 9.1. Introduction
• 9.2. Homecare
• 9.3. Hospitals
• 9.4. Research institute
• 9.5. Specialty Clinics

10. Pregabalin Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Hospital Pharmacy
• 10.3. Online Pharmacy
• 10.4. Retail Pharmacy

11. Americas Pregabalin Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Pregabalin Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Pregabalin Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. FPNV Positioning Matrix
• 14.2. Market Share Analysis, By Key Player
• 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

• 16.1. Discussion Guide
• 16.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. PREGABALIN MARKET RESEARCH PROCESS
• FIGURE 2. PREGABALIN MARKET SIZE, 2022 VS 2030
• FIGURE 3. PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2022 VS 2030 (%)
• FIGURE 5. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
• FIGURE 6. PREGABALIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. PREGABALIN MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
• FIGURE 8. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 9. PREGABALIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 10. PREGABALIN MARKET DYNAMICS
• FIGURE 11. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. PREGABALIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. PREGABALIN MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 20. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 21. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PREGABALIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 5. PREGABALIN MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PREGABALIN MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PREGABALIN MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PREGABALIN MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 10. PREGABALIN MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PREGABALIN MARKET SIZE, BY FIBROMYALGIA AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. PREGABALIN MARKET SIZE, BY ANXIETY DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PREGABALIN MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 17. PREGABALIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. PREGABALIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. PREGABALIN MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. PREGABALIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. PREGABALIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. CANADA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. CANADA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. CHINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. INDIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. ITALY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ITALY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 163. ITALY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. POLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. POLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 183. POLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. QATAR PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. QATAR PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 188. QATAR PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 234. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 235. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 236. PREGABALIN MARKET LICENSE & PRICING